Ticker Details
LivaNova PLC Ordinary Shares LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.
IPO Date:	October 19, 2015
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$4.34B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.01 | 1.61%
Avg Daily Range (30 D):	$1.50 | 1.86%
Avg Daily Range (90 D):	$1.39 | 1.89%

Institutional Daily Volume
Avg Daily Volume:	.41M
Avg Daily Volume (30 D):	.52M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	7,018
Avg Institutional Trade:	$2.59M
Avg Institutional Trade (30 D):	$4.38M
Avg Institutional Trade (90 D):	$4.33M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.66M
Avg Closing Trade (30 D):	$7.39M
Avg Closing Trade (90 D):	$9.65M
Avg Closing Volume:	58.76K

News

Jun 27, 2026 @ 8:30 AM Brain Implants Market Size to Reach USD 18.39 Bill... Source: Sns Insider

Apr 23, 2026 @ 5:00 PM Global Perfusion Systems Market to Register Increm... Source: Delveinsight

Mar 27, 2026 @ 2:15 PM MedTech's Edge: How AI and Remote Diagnostics Driv... Source: Equity Insider

Feb 23, 2026 @ 6:00 PM Global Neuromodulation Devices Market Anticipating... Source: Delveinsight

Jan 26, 2026 @ 1:32 AM From Humanoid Robots to AI Seating: VivaNova Debut... Source: Not Specified

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$3.44	$1.98	$.41
Diluted EPS	$3.38	$1.93	$.4
Revenue	$1.47B	$390.59M	$362.26M
Gross Profit	$1B	$273.67M	$243.75M
Net Income / Loss	$188.55M	$108.57M	$22.29M
Operating Income / Loss	$187.55M	$49.48M	$41.47M
Cost of Revenue	$469.47M	$116.92M	$118.51M
Net Cash Flow	$-77.02M	$-23.09M	$-95.85M
PE Ratio